Clovis Oncology (CLVS) was upgraded to outperform from neutral at Credit Suisse. $41 price target. The company is an attractive takeover target, Credit Suisse said.
Fair Isaac (FICO) was downgraded to equal-weight from overweight at Barclays. $135 price target. The valuation is less attractive, with the stock up 78% since 2015, Barclays said.
Altria (MO) was initiated with a hold rating at Jefferies. $70 price target. Marlboro will likely face increased market share pressure in the next 18 months, Jefferies said.
Monsanto (MON) was upgraded to overweight from neutral at JPMorgan. $128 price target. The Risk/reward is attractive, given the Bayer takeover offer, JPMorgan said.
Children's Place (PLCE) was downgraded to neutral from overweight at Piper Jaffray. $88 price target. The company could see margins compress, Piper said.
Post (POST) was downgraded to market perform at BMO Capital. $83 price target. The analyst sees lower profit potential for Michael's egg business, BMO said.
Sketchers USA (SKX) was downgraded to equal-weight from overweight at Morgan Stanley. $25 price target. Earnings estimates were also cut, as consumer trends are shifting toward pure fashion items, Morgan Stanley said.
Wells Fargo (WFC) was downgraded to neutral from overweight at JPMorgan. $48 price target. Probes will likely expand and uncertainty is building, JPMorgan said.